Lennox-Gastaut syndrome is one of the most severe forms of childhood epilepsy, defined by a combination of multiple hard-to-treat seizure types, a distinctive brainwave pattern on EEG, and cognitive difficulties that typically worsen over time. It accounts for a small but outsized share of the burden of epileptic encephalopathies, usually appearing between ages one and seven. The syndrome resists most standard treatments and persists into adulthood, making it a lifelong condition that affects not just the person diagnosed but the entire family around them.
What Lennox-Gastaut Syndrome Looks Like
The hallmark of LGS is not a single seizure type but a mix of several, often occurring many times a day. Tonic seizures, where the body stiffens suddenly, are the most characteristic and tend to cluster during sleep. Atonic seizures involve a sudden loss of muscle tone, causing the person to collapse without warning. These “drop attacks” resolve within seconds but carry a high risk of head and facial injuries because the person has no time to brace for a fall.1PubMed Central. Epileptic drop attacks: More than just atonic seizures Many children also experience atypical absence seizures, brief episodes of staring or reduced awareness that can be hard to distinguish from normal inattention.
The sheer variety of seizure types in one person is part of what makes LGS so difficult to manage. A child might have tonic seizures at night, drop attacks during the day, and absences scattered throughout, each type responding differently to medication. Drop attacks are often the most distressing for families because of the constant risk of injury and the need for protective helmets.2Neurosciences Journal. Lennox-Gastaut syndrome
How It Develops
LGS rarely appears out of nowhere. A substantial number of children diagnosed with it have a history of an earlier epilepsy syndrome, particularly infantile spasms (also called West syndrome). One longitudinal study tracking children with early developmental epilepsies found that by the end of follow-up, 22 children had been diagnosed with LGS, including 7 who had evolved from infantile spasms and 12 from other nonsyndromic generalized, focal, or undetermined epilepsies.3PubMed Central. Evolution and course of early life developmental encephalopathic epilepsies: Focus on Lennox-Gastaut syndrome That progression from infantile spasms to LGS is well recognized by epileptologists, and when a child with a history of spasms starts developing new seizure types and their EEG shifts, clinicians watch closely for the transition.
The condition can also arise without a clear preceding epilepsy syndrome. In some children, LGS is the first epilepsy diagnosis, triggered by a structural brain abnormality, a genetic variant, or an acquired injury such as meningitis or a perinatal insult. In cases where no clear cause is found, the syndrome is classified as having an unknown etiology, though advances in genetic testing are steadily shrinking that category.
Causes and Genetics
LGS is better understood as a shared endpoint reached by many different routes rather than a single disease with a single cause. The underlying etiologies are diverse: structural brain malformations, brain injuries from infection or oxygen deprivation, chromosomal abnormalities, and single-gene mutations can all lead to the same clinical picture. One study of children with LGS found that about a quarter had an acquired structural cause identified on neuroimaging, while genetic testing identified pathogenic variants in roughly a third of the remaining patients with nonacquired etiologies.
Genetic research has revealed an unexpectedly wide range of genes involved. A study of Korean families identified mutations in 14 different genes associated with LGS or LGS-like epilepsy, with about two-thirds of those genes already known to be linked to epilepsy and many of the specific mutations being novel.4PubMed Central. Characteristics of Genetic Variations Associated With Lennox-Gastaut Syndrome in Korean Families Separately, research using advanced genome sequencing on a small cohort of LGS patients found clinically relevant genetic variants in four of six patients, including a pathogenic variant in the KCNA2 gene and, for the first time, tandem repeat expansions that had never been reported in LGS before.5Brain Communications. Genome sequencing identifies rare tandem repeat expansions and copy number variants in Lennox–Gastaut syndrome
Copy number variants, where chunks of DNA are duplicated or deleted, also play a role. In one study of adult LGS patients, about 38% carried rare copy number variants that might contribute to their condition, with a causative role considered highly probable in roughly one in five patients. Some of these overlapped with recognized genetic syndromes such as 22q13.3 deletion and MECP2 duplication.6PubMed. Copy number variants in adult patients with Lennox-Gastaut syndrome features The practical upshot for families is that genetic testing is increasingly worthwhile even in cases where a cause seems unclear, because finding a specific variant can sometimes guide treatment decisions or connect families with syndrome-specific research.
Why the Brain Behaves This Way
One of the reasons LGS is so difficult to treat is that the seizures do not originate from a single spot in the brain that a surgeon could remove. Researchers have proposed that LGS operates as a “secondary network epilepsy,” meaning the epileptic activity hijacks large-scale brain networks, particularly those involved in attention and awareness, rather than firing from one focal point.7PubMed Central. Conceptualizing lennox-gastaut syndrome as a secondary network epilepsy When a structural lesion is present, it appears to chronically destabilize these networks rather than directly triggering each individual seizure. This network-level instability helps explain the EEG signature, the slow spike-and-wave pattern that defines LGS, as well as why so many different seizure types coexist in the same person. It also explains why the cognitive effects are so pervasive: the same attention and awareness networks that get disrupted by seizures are the ones children rely on for learning and processing information.
Medication Options
No single drug controls LGS well, and most patients end up on combinations of two, three, or more anti-seizure medications. Several drugs have been specifically approved for LGS, though each comes with trade-offs. Clobazam, a benzodiazepine approved in the United States in 2011 as an add-on treatment for LGS, has shown sustained effectiveness with a better tolerability profile than older benzodiazepines. The trials leading to its approval demonstrated that more than half of LGS patients achieved at least a 50% reduction in seizures, a benchmark none of the other approved LGS treatments have matched head-to-head.8PubMed Central. Experience in the use of clobazam in the treatment of Lennox-Gastaut syndrome
Cannabidiol (CBD), marketed as Epidiolex, brought a new mechanism into the LGS toolbox. A large randomized trial found that adding CBD at 20 mg/kg/day reduced drop seizures by about 42% compared with roughly 17% for placebo, a statistically meaningful difference.9PubMed. Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome Fenfluramine, a drug originally known as a weight-loss medication, was repurposed after researchers discovered its anti-seizure properties. In a randomized trial, the higher-dose fenfluramine group saw a median reduction of about 27 percentage points in drop seizure frequency versus about 8 percentage points for placebo, and the overall difference from placebo was close to 20 percentage points.10JAMA Neurology. Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial
Other medications used include valproate, lamotrigine, rufinamide, and felbamate. A Cochrane systematic review covering multiple agents found high-certainty evidence that felbamate roughly tripled the odds of achieving at least a 50% seizure reduction compared with placebo.11PubMed Central. Anti‐seizure medications for Lennox‐Gastaut syndrome However, felbamate carries a rare but serious risk of liver failure and aplastic anemia, so it tends to be reserved for cases where other options have failed. The reality for most families is a process of trial and error, layering medications one at a time and watching for both benefits and side effects that can compound as the drug list grows.
The Ketogenic Diet
When medications alone fall short, dietary therapy becomes a serious option. The ketogenic diet, a high-fat, very-low-carbohydrate eating plan that shifts the body’s primary fuel source from glucose to ketones, has decades of use in drug-resistant epilepsy and shows particular promise in LGS. A retrospective review of 71 children with LGS found that after six months on the diet, about half had more than a 50% seizure reduction, roughly a quarter had more than 90% reduction, and one child became seizure-free. Those results held at 12 months.12PubMed. Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution’s experience and summary of the literature Other studies have confirmed that the diet can also improve EEG abnormalities in addition to reducing seizure counts.13PubMed. Therapeutic effects of the ketogenic diet in children with Lennox-Gastaut syndrome
The diet is demanding. It requires careful meal planning, frequent blood and urine monitoring, and a level of dietary precision that affects the whole household. Modified versions, including the modified Atkins diet and the low glycemic index treatment, offer somewhat more flexibility while preserving a ketogenic state, and review literature suggests these variants can also be applied safely in LGS.14PubMed Central. Ketogenic Diets in the Management of Lennox-Gastaut Syndrome-Review of Literature For families who can sustain it, the diet serves as a valuable complement to medication rather than a replacement for it.
Surgical and Neuromodulation Approaches
Because LGS involves diffuse brain networks, traditional resective surgery, removing the brain region where seizures start, is rarely an option. The main surgical procedure used instead is corpus callosotomy, which severs the thick band of nerve fibers connecting the two brain hemispheres. This does not cure the epilepsy but can dramatically reduce or eliminate drop attacks by preventing seizure activity from spreading rapidly between hemispheres.15PubMed. Corpus callosotomy is a valuable therapeutic option for patients with Lennox-Gastaut syndrome and medically refractory seizures A newer, less invasive version uses stereotactic laser ablation to cut the front portion of the corpus callosum through a small burr hole rather than open surgery. In one series, 80% of patients had more than an 80% reduction in drop attacks, with half becoming completely free of them.16PubMed. Stereotactic laser anterior corpus callosotomy for Lennox-Gastaut syndrome
Vagus nerve stimulation (VNS), in which a pacemaker-like device sends regular electrical pulses to the brain via the vagus nerve in the neck, is widely used as a palliative measure. It tends to produce a modest but cumulative seizure reduction over months to years. Deep brain stimulation (DBS), which implants electrodes directly into specific brain structures, is a more experimental but increasingly studied option. A systematic review of DBS for LGS found that patients averaged more than a 50% seizure reduction, with two becoming seizure-free, at a mean follow-up of about 15 months.17PubMed Central. Management of Lennox-Gastaut syndrome with deep brain stimulation: A systematic literature review A separate institutional series targeting a specific brain region, the centromedian thalamic nucleus, reported that four of six pediatric patients achieved more than a 60% reduction in seizure frequency.18PubMed. Deep Brain Stimulation of Bilateral Centromedian Thalamic Nuclei in Pediatric Patients with Lennox-Gastaut Syndrome: An Institutional Experience DBS remains reserved for patients who have not responded to medications, diet, or other surgical options, but it represents a growing frontier for the most treatment-resistant cases.
Getting the Diagnosis Right
LGS shares features with several other childhood epilepsy syndromes, and misdiagnosis is a real problem. A child who has epileptic falls does not necessarily have LGS, but many do, and sorting out which syndrome is present requires careful analysis of both the seizure patterns and the EEG characteristics.19Epileptic Disorders. All children who experience epileptic falls do not necessarily have Lennox‐Gastaut syndrome… but many do Conditions that can mimic LGS include Dravet syndrome, epilepsy with myoclonic-atonic seizures (Doose syndrome), and atypical benign partial epilepsy of childhood. Each has a different prognosis and responds differently to treatment, so getting the distinction right matters.
The EEG is critical here. The slow spike-and-wave pattern in LGS (typically under 2.5 Hz) looks different from the 3 Hz spike-and-wave seen in childhood absence epilepsy and from the patterns in Dravet syndrome. During sleep, LGS often shows runs of fast rhythmic activity called generalized paroxysmal fast activity, a feature that further helps confirm the diagnosis.20Wiley Online Library (Epilepsia). Lennox-Gastaut syndrome: a consensus approach to differential diagnosis Because the full clinical picture of LGS can take months or years to declare itself, some children initially receive a different diagnosis that later gets revised as new seizure types emerge and the EEG evolves.
Living with LGS into Adulthood
LGS does not end at childhood. The seizures generally persist into adulthood, though the mix of seizure types may shift over the years. Despite decades of treatment advances, the condition remains a form of intractable epilepsy for most people.21PubMed. Long-term prognosis of patients with Lennox–Gastaut syndrome in recent decades Cognitive difficulties, already present in childhood, tend to worsen or at best plateau, and studies of adults with LGS highlight significant impairments in adaptive behavior, the daily living skills needed for independence.22PubMed Central. Long-term outcomes and adaptive behavior in adult patients with Lennox-Gastaut syndrome Most adults with LGS require lifelong supervision and support with basic activities such as managing medication, preparing food, and navigating community settings.
Effective long-term management requires looking well beyond seizure control. Behavioral challenges, sleep disturbances, physical disability from years of falls and medication side effects, and the educational and psychosocial needs of the individual all demand attention. A global approach to care, one that addresses the whole person rather than just the seizure count, consistently produces better quality of life than a seizure-focused strategy alone.
The Transition Gap
One of the most fraught periods for people with LGS and their families is the transition from pediatric to adult medical care. In pediatric settings, epileptologists, neuropsychologists, therapists, and social workers often coordinate closely. When a patient ages out, that coordination can fall apart. Research on transition outcomes has found widespread dissatisfaction with the process, particularly for patients with intellectual disability. Those who are not successfully transitioned may lose access to specialty care, miss out on newer therapies, and go without adequate follow-up for the comorbid conditions that accompany LGS.23PubMed. Strategies for transitioning to adult care for youth with Lennox-Gastaut syndrome and related disorders Adult neurologists, for their part, often have less experience with LGS than their pediatric counterparts, since the syndrome is diagnosed in childhood and many training programs spend relatively little time on it.
The barriers are both clinical and logistical. Families accustomed to a familiar care team resist handing off to unknown providers. Adult care systems may lack the multidisciplinary structure that LGS patients need. And the patients themselves, often unable to advocate for their own care, depend on family members to navigate a system that was not designed for them.24PubMed. Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review Dedicated transition clinics, where pediatric and adult providers overlap for a period of time, have been proposed as a solution, but they remain the exception rather than the rule in most healthcare systems.
The Weight on Families
Caring for a person with LGS reshapes virtually every aspect of family life. When parents of children with LGS were asked how the condition affected their families, the answers centered on continuous stress, major financial strain, and a lack of time for other children in the household.25PubMed Central. Lennox-Gastaut syndrome: impact on the caregivers and families of patients The seizures themselves generate constant anxiety about injury, but the cognitive and behavioral challenges that accompany LGS can be equally exhausting. Many families report that the behavioral difficulties, aggression, sleep disruption, and the inability of the child to communicate needs are harder to cope with on a daily basis than the seizures.
The care burden intensifies as the child grows. A small child who has a drop attack is one thing; an adolescent or adult who collapses is a much greater physical challenge for a caregiver. Literature reviews describe the overall experience as one of chronic burden, with effects on the physical, emotional, social, and financial health of the whole family unit.26PubMed. Impact of Lennox-Gastaut Syndrome (LGS) on health-related quality of life (HRQL) of patients and caregivers: literature review Respite care, peer support networks, and proactive management of caregiver mental health are consistently recommended by specialists but inconsistently available in practice.
How the Syndrome Got Its Name
The path to recognizing LGS as a distinct entity was a transatlantic effort that spanned decades. In the late 1930s, Frederic and Erna Gibbs in the United States identified a characteristically slow spike-and-wave pattern on EEG that they called the “petit mal variant,” distinguishing it from the faster 3 Hz pattern seen in classic absence epilepsy. William G. Lennox, working alongside them, was the first to put the pieces together: he described children who had the slow spike-and-wave pattern, intellectual disability, and a combination of seizure types including drops, myoclonic jerks, and atypical absences.27PubMed. History of Lennox-Gastaut Syndrome: An electro-clinical voyage in search of an epileptic syndrome
In France, Henri Gastaut organized a series of symposia in Marseille through the 1960s to refine the concept. Charlotte Dravet’s doctoral dissertation, published as a paper by Gastaut and colleagues in 1966 with 50 additional cases, formalized the syndrome. Gastaut initially proposed calling it “Lennox syndrome.” It was Margaret Lennox-Buchthal, William Lennox’s daughter, who suggested at a 1966 meeting that the condition carry both names, crediting her father’s original description and the Marseille school’s subsequent work in confirming and expanding it. The dual eponym stuck, and LGS has been known by that name ever since.